Decreased Alcohol Intake Associated with the Practice of Meditation: A Retrospective Investigation

Authors
Herbert Benson
Publication
Annals of the New York Academy of Sciences
Volume 233, Issue 1
Abstract

A wakeful hypometabolic state accompanies the practice of a relaxational, meditation technique called Transcendental Meditation. The state is characterized by decreased oxygen consumption, carbon dioxide elimination, respiratory rate and minute ventilation, with no change in respiratory quotient. Arterial blood pH and base excess decrease slightly while arterial blood lactate markedly decreases. Systolic, diastolic, and mean arterial blood pressures remain unchanged. The electroencephelogram shows an increase in intensity of slow alpha waves and occasional theta wave activity. These physiologic changes differ from those occurring during sleep and are hypothesized to represent activation of an integrated hypothalmic response, which is associated with decreased sympathetic nervous system activity.

A previously reported retrospective investigation noted decreased drug abuse and alcoholic intake associated with the practice of meditation. A portion of these same data are again reported.

Related Listings
Meditation and Cardiovascular Risk Reduction: A...
Authors
Glenn N. Levine, Richard A. Lange, C. Noel Bairey-Merz
Journal
Journal of the American Heart Association
Provides 37 pages of summaries from decades of research concerning how meditation affects heart related functioning (blood pressure, heart rate, etc.) Abstract Despite numerous advances in the prevention and treatment of atherosclerosis, cardiovascular disease remains a leading cause of morbidity and mortality. Novel and inexpensive interventions that can contribute to the primary and secondary prevention of cardiovascular disease are of interest. Numerous studies have reported on the […]
Neurobiology of Stress
Journal
Neurobiology of Stress
Journal devoted to the neurobiology of stress
Kundalini Yoga Meditation Versus the Relaxation...
Authors
David Shannahoff-Khalsa, Rodrigo Yacubian Fernandes, Carlos A. de B. Pereira, John S. March, James F. Leckman, Shahrokh Golshan, Mario S.R. Vieira, Guilherme V. Polanczyk, Euripedes C. Miguel, Roseli G. Shavitt
Journal
Frontiers in Psychiatry
Background: Obsessive-compulsive disorder (OCD) is often a life-long disorder with high psychosocial impairment. Serotonin reuptake inhibitors (SRIs) are the only FDA approved drugs, and approximately 50% of patients are non-responders when using a criterion of 25% to 35% improvement with the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). About 30% are non-responders to combined first-line therapies (SRIs and exposure and response prevention). Previous research (one open, one randomi […]